BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6307579)

  • 21. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of technetium 99m MDP by hepatoblastoma.
    Cory DA; Siddiqui AR; Cohen MD
    Eur J Nucl Med; 1987; 12(11):546-7. PubMed ID: 3032638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
    Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
    Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
    [No Abstract]   [Full Text] [Related]  

  • 24. Concentration and clearance of Tc-99m-pyridoxylidene isoleucine by a hepatoma.
    Ueno K; Haseda Y
    Clin Nucl Med; 1980 May; 5(5):196-9. PubMed ID: 6245828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonvisualization of hepatoma with Tc-99m hepatobiliary agent.
    Lamki N; Raval B; Chamberlain M
    J Nucl Med; 1981 Mar; 22(3):293. PubMed ID: 6259304
    [No Abstract]   [Full Text] [Related]  

  • 26. Unusual Tc-99m methylene diphosphonate uptake by clinically suspected adrenal metastases from hepatocellular carcinoma.
    Lin LF; Cheng CY; Hou CH; Shen DH
    Clin Nucl Med; 2011 Dec; 36(12):e207-8. PubMed ID: 22064112
    [No Abstract]   [Full Text] [Related]  

  • 27. Diffuse pulmonary ossification detected by bone scanning with Tc-99m hydroxymethylene diphosphate.
    Saks DA; McClees EC; Fajman WA; Hollinger WM; Gilman MJ
    Clin Nucl Med; 1984 Oct; 9(10):594-5. PubMed ID: 6435921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new bone scanning agent: clinical experience of 99mTc-hydroxymethane diphosphonate (HMDP) (author's transl)].
    Fukunaga M; Fujita T; Shigeno C; Morita R; Torizuka K
    Kaku Igaku; 1981 Jul; 18(6):863-7. PubMed ID: 7311135
    [No Abstract]   [Full Text] [Related]  

  • 29. Technetium-99m hydroxymethylene diphosphonate scanning of acute injuries to the lateral ligaments of the ankle.
    Maurice H; Watt I
    Br J Radiol; 1989 Jan; 62(733):31-4. PubMed ID: 2914189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
    Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
    Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An experimental crossover study between hydroxymethylene diphosphonate kit and methylene diphosphonate (author's transl)].
    Nagai K; Muranaka A; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Ito Y
    Radioisotopes; 1982 Jan; 31(1):32-4. PubMed ID: 6461888
    [No Abstract]   [Full Text] [Related]  

  • 32. [Concentration of 99mTc methylen-diphosphonate in pulmonary small cell anaplastic carcinoma and hepatic metastasis from pulmonary adenocarcinoma. Report of two cases (author's transl)].
    Okimura T; Miyamura T; Yamamoto T; Higashi K; Nishiki M; Hamada S; Miyatani H; Kobayashi M; Tonami H; Takarada A; Yamagishi T; Tani K
    Rinsho Hoshasen; 1982 Jan; 27(1):127-30. PubMed ID: 6281487
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic hydrothorax demonstrated on bone imaging.
    Chu YK; Liu RS; Yeh SH
    Clin Nucl Med; 1990 Feb; 15(2):131-2. PubMed ID: 2155730
    [No Abstract]   [Full Text] [Related]  

  • 34. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent].
    Ishine M; Kawamura M; Koizumi M; Itoh H; Murase K; Inatsuki S; Iio A; Hamamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):389-97. PubMed ID: 6214765
    [No Abstract]   [Full Text] [Related]  

  • 35. What causes uptake of technetium-99m methylene diphosphonate by tumors? A case where the tumor appeared to secrete a hypercalcemia-causing substance.
    Stone CK; Sisson JC
    J Nucl Med; 1985 Mar; 26(3):250-3. PubMed ID: 3156221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritoneal carcinomatosis from ruptured hepatocellular carcinoma on bone scintigraphy.
    Gi MT; Ho YY
    Clin Nucl Med; 2005 Nov; 30(11):744-6. PubMed ID: 16237302
    [No Abstract]   [Full Text] [Related]  

  • 37. Scintigraphic "doughnut sign" on bone scintigraphy secondary to metastatic hepatocellular carcinoma.
    Hirano T; Otake H; Kanuma M; Mogi Y; Tatezawa T
    Clin Nucl Med; 1995 Nov; 20(11):1020-1. PubMed ID: 8565359
    [No Abstract]   [Full Text] [Related]  

  • 38. Photon-deficient bone metastases in hepatocellular carcinoma.
    Ikehira H; Furuichi Y; Mizuno S; Segawa H; Nakamura H; Kimura S; Yamamoto S; Takano H; Ito H; Aoki T
    Clin Nucl Med; 1998 May; 23(5):329-30. PubMed ID: 9596165
    [No Abstract]   [Full Text] [Related]  

  • 39. Accumulation of Tc-99m methylene diphosphonate in calcified metastatic lesions of the liver from colonic carcinoma. Comparison with calcification on X-ray computed tomogram.
    Senda M; Tamaki N; Torizuka K; Fujiwara Y; Kudo M; Tochio H; Ito H; Yamaguchi H; Saiki Y; Ikekubo K
    Clin Nucl Med; 1985 Jan; 10(1):9-12. PubMed ID: 3156710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
    Haseman MK
    Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.